Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001104659-13-016675
Filing Date
2013-03-01
Accepted
2013-03-01 13:48:15
Documents
3

Document Format Files

Seq Description Document Type Size
1 8-K a13-6343_18k.htm 425 27902
2 EX-99.1 a13-6343_1ex99d1.htm EX-99.1 23927
3 GRAPHIC g63431mmi001.jpg GRAPHIC 5045
  Complete submission text file 0001104659-13-016675.txt   60670
Mailing Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filed by) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Subject) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-31812 | Film No.: 13656232
SIC: 2836 Biological Products, (No Diagnostic Substances)